Human apolipoprotein A-IV (apo-IV) is a plasma protein whose most distinctive property is its labile affinity for the surface of plasma lipoprotein. Although the specific function of apo A-IV in lipid metabolism has not yet been determined, studies, conducted by the Principal Investigator have contributed to a growing body of evidence which implicates apo A-IV as an important factor in the intravascular metabolism of high density lipoprotein (HDL). Recent studies now suggest that the labile binding of apo A-IV to lipid surfaces may be central to its physiological function. Specifically, we have proposed that the labile binding of apo A-IV to HDL constitutes a barostatic mechanism which maintains the surface pressure of HDL in a critical range required for optimal activity of lecithin-cholesterol acyltransferase (LCAT) and cholesterol ester transfer protein (CETP). The purpose of this proposal is to investigate the impact of molecular structure on the interaction of apo A-IV and phospholipid, with particular regard tot he molecular mechanism of the CETP reaction. We therefore propose four specific aims: 1) Recombinant apo A-IV deletion mutants will be studied by spectroscopic and surface balance techniques to examine the effect of specific amino acid domains on its ordered structure, thermodynamic stability, and lipid affinity; 2) The interaction of recombinant apo A-IV deletion mutants and phospholipid will be studied by physico-chemical techniques to examine the impact of protein structure on the properties and LCAT reactivity of apo A-IV/lipid complexes; 3) The interaction of CETP and HDL will be investigated using fluorescent labelled recombinant and native HDL to determine the mechanisms by which apo A-IV facilitates CETP-catalyzed lipid exchanges and the interconversion of HDL subspecies; 4) CETP will be studied using surface balance techniques to elucidate the mechanisms of the reaction and the role of apo A-IV facilitates CETP-catalyzed lipid exchanges and the interconversion of HDL subspecies; 4) CETP will be studied using surface balance techniques to elucidate the mechanisms of the reaction and the role of apo A-IV in lipid exchange phenomena. The investigation of the structure and function of the plasma apolipoproteins has led to major advances in the diagnosis, treatment, and prevention to atherosclerotic cardiovascular disease, the leading cause of death in the USA. The long term goal of this proposal is to delineate the physiological functions of human apo A-IV.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL030897-11
Application #
2216719
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1990-08-01
Project End
1999-05-30
Budget Start
1995-06-01
Budget End
1996-05-31
Support Year
11
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
McKimmie, Ryan L; Easter, Linda; Weinberg, Richard B (2013) Acyl chain length, saturation, and hydrophobicity modulate the efficiency of dietary fatty acid absorption in adult humans. Am J Physiol Gastrointest Liver Physiol 305:G620-7
VerHague, Melissa A; Cheng, Dongmei; Weinberg, Richard B et al. (2013) Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion. Arterioscler Thromb Vasc Biol 33:2501-8
Weinberg, Richard B; Gallagher, James W; Fabritius, Melissa A et al. (2012) ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins. J Lipid Res 53:736-43
Simon, Trang; Cook, Victoria R; Rao, Anuradha et al. (2011) Impact of murine intestinal apolipoprotein A-IV expression on regional lipid absorption, gene expression, and growth. J Lipid Res 52:1984-94
Blade, Anna M; Fabritius, Melissa A; Hou, Li et al. (2011) Biogenesis of apolipoprotein A-V and its impact on VLDL triglyceride secretion. J Lipid Res 52:237-44
Weinberg, Richard B; Cook, Victoria R (2010) Distinctive structure and interfacial activity of the human apolipoprotein A-IV 347S isoprotein. J Lipid Res 51:2664-71
Ledford, Aubrey S; Cook, Victoria A; Shelness, Gregory S et al. (2009) Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B. J Lipid Res 50:108-15
Wong, Wai-Man R; Gerry, Andrew B; Putt, Wendy et al. (2007) Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation. Atherosclerosis 192:266-74
Beckstead, Jennifer A; Wong, Kasuen; Gupta, Vinita et al. (2007) The C terminus of apolipoprotein A-V modulates lipid-binding activity. J Biol Chem 282:15484-9
Weinberg, R B (1994) Identification of functional domains in the plasma apolipoproteins by analysis of inter-species sequence variability. J Lipid Res 35:2212-22

Showing the most recent 10 out of 11 publications